Attorney General Mark Brnovich recently made headlines after the public learned of his investigation into the marketing practices of an opioids manufacturer. The firm under scrutiny is located in Arizona and according to reports from Tucson, Insys Therapeutics has filed paperwork with the Securities and Exchange Commission. Information from this paperwork reveals that the Arizona firm has been under previous investigations from officials in and out of state. It appears as though Mark Brnovich’s investigation into the manufacturers of opioids is quite necessary, indeed.
Opioids are defined by Drug Abuse as “a class of drugs that include the illegal drug heroin, synthetic opioids such as fentanyl, and pain relievers available legally by prescription, such as oxycodone (OxyContin®), hydrocodone (Vicodin®), codeine, morphine, and many others.” Any manufacturer that produces opioids should be under a watchful eye due to the astronomical impact that the drugs can have on the human mind and body. It appears as though the Arizona firm has engaged in practices with Insys that attracted several subpoenas.
